TABLE II.
Who orders EGFR mutation testing, by specialty and region
| Respondent category (n of 135 surveyed) | Response [n (%)]a | ||||
|---|---|---|---|---|---|
|
| |||||
| Respiratory medicine | Thoracic surgery | Radiation oncology | Pathology | Medical oncology | |
| All respondents (116) | 30 (26) | 16 (14) | 22 (19) | 26 (22) | 105 (91) |
| Specialty | |||||
| Pathology (15) | 1 (7) | 1 (7) | 5 (33) | 3 (20) | 14 (93) |
| Medical oncology (51) | 6 (12) | 9 (18) | 9 (18) | 8 (16) | 50 (98) |
| Respiratory medicine (50) | 23 (46) | 6 (12) | 8 (16) | 15 (30) | 41 (82) |
| Region | |||||
| West (35) | 4 (11) | 2 (6) | 10 (29) | 8 (23) | 32 (91) |
| Ontario (43) | 10 (23) | 8 (19) | 9 (21) | 6 (14) | 40 (93) |
| Quebec (31) | 16 (52) | 5 (16) | 3 (10) | 10 (32) | 26 (84) |
| East (7) | 0 (0) | 1 (14) | 0 (0) | 2 (29) | 7 (100) |
a
More than one response was permitted.